Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus

OncoTargets and Therapy

Volumn 6, Issue , 2013, Pages 1147-1151

  Feng, Ji Feng ^a   Zhao, Hong Guang ^a   Liu, Jin Shi ^a   Chen, Qi Xun ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

C reactive protein; Esophageal cancer; Small cell carcinoma; Survival

Indexed keywords

C REACTIVE PROTEIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; PACLITAXEL; PLATINUM COMPLEX;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; FEMALE; HAZARD RATIO; HUMAN; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIATION DOSE; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; SMALL CELL CARCINOMA OF THE ESOPHAGUS; TUMOR INVASION;

EID: 84883306874     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S50039     Document Type: Article

References (19)

1. McKeown F. Oat-cell carcinoma of the oesophagus. J Pathol Bacteriol. 1952;64(4):889-891.
2. Koide N, Saito H, Suzuki A, et al. Clinicopathologic features and histochemical analyses of proliferative activity and angiogenesis in small cell carcinoma of the esophagus. J Gastroenterol. 2007;42(12): 932-938.
3. Brenner B, Tang LH, Shia J, Klimstra DS, Kelsen DP. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin Oncol. 2007;34(1):43-50.
4. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539-545.
5. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-444.
6. Nakanishi H, Araki N, Kudawara I, et al. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma. Int J Cancer. 2002;99(2):167-170.
7. Platt JJ, Ramanathan ML, Crosbie RA, et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol. 2012;19(13): 4168-4177.
8. Shimada H, Nabeya Y, Okazumi S, et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2003;83(4):248-252.
9. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg. 2001;182(2):197-201.
10. Guillem P, Triboulet JP. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus. 2005;18(3):146-150.
11. Casas F, Ferrer F, Farrus B, Casals J, Biete A. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer. 1997;80(8):1366-1372.
12. Hudson E, Powell J, Mukherjee S, et al. Small cell oesophageal carcinoma: an institutional experience and review of the literature. Br J Cancer. 2007;96(5):708-711.
13. Jatoi A, Miller RC. Should we recommend surgery to patients with limited small cell carcinoma of the esophagus? J Thorac Oncol. 2008;3(12):1373-1376.
14. Vos B, Rozema T, Miller RC, et al. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study. Dis Esophagus. 2011;24(4):258-264.
15. Zimmerman MA, Selzman CH, Cothren C, et al. Diagnostic implications of C-reactive protein. Arch Surg. 2003;138(2):220-224.
16. Szalai AJ, VanCott JL, McGhee JR, et al. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun. 2000;68(10):5652-5656.
17. Szalai AJ, Briles DE, Volanakis JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol. 1995;155(5):2557-2563.
18. Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4): 155-170.
19. Groblewska M, Mroczko B, Sosnowska D, Szmitkowski M. Interleukin 6 and C-reactive protein in esophageal cancer. Clin Chim Acta. 2012;413(19-20):1583-1590.